← SynDRA
RIBAVIRIN
SynDRA canonical compound SYN0016059 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | IMPDH1 |
| Mechanism of action | Antiviral |
| Indication | hepatitis C |
| Disease area | infectious disease |
All known targets
- IMPDH1
- ADK
- ENPP1
- IMPDH2
- NT5C2
- ADORA1
- Adora1
- NS5B
- TOP1
Mechanisms of action (all sources)
- Antiviral
- IMPDH1 INHIBITOR
- Inosine-5'-monophosphate dehydrogenase 1 inhibitor
- NS5B INHIBITOR
Drug classes
- Nucleoside Analog Antiviral
- Anti-Infective Agents
- Antimetabolites
- Antiviral Agents
- Noxae
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- ribamide
- ribamidil
- ribavarin
- tribavirin
- Tribavirin
- Ribavirine
- Ribavirina
- Cotronak
- Ribavirin biopartners
- Ribavirin mylan
- Ribavirin teva
- NSC-163039
- SCH-18908
- Copegus
- Rebetol
- Ribapak
- Ribasphere
- Ribavarin
- Ribavirin mylan (previously ribavirin three rivers)
- Ribavirin teva pharma b.v.
- Ribofluranosyl carboxamide
- Viramid
- Virazid
- Virazole
- Vilona
- Ribamide
- Ribamidil
- Ribamidyl
- Ribavirinum
- Rebetron
- Varazid
- RTCA
- Ribavirin Capsules
- Ribavirinum [INN-Latin]
- Ribavirine [INN-French]
- Ribavirina [INN-Spanish]
- ICN-1229
- Rebretron
Reported adverse events
- Hemolytic anemia
- Rash
- Seizure
- Cardiac arrest
- Death
- Alopecia
- Arthralgia
- Depression
- Fatigue
- Headache
- Pruritus
- Asthenia
Look up RIBAVIRIN in the interactive SynDRA portal →